UNSPSC 85446901: The diagnosis of contaminated medical or biological substance, transfused or infused

In this classification, this covers the group of activities that yields a diagnosis of contaminated medical or biological substance, transfused or infused. Contaminated medical or biological substance, transfused or infused is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y64.0.

UNSPSC 85446901 The diagnosis of contaminated medical or biological substance, transfused or infused (Commodity) shows no recent state and local contract solicitation activity aligned with the code's nominal scope. The three most-recent opportunities posted under this code—a diagnostic imaging Picture Archiving and Communication System (PACS) implementation by San Mateo Medical Center, special education contracted services by Birdville Independent School District, and a temporary health professional staffing qualification vehicle by the County of Santa Clara Health System—do not involve diagnosis of contaminated transfused or infused substances. The PACS solicitation addresses enterprise imaging system architecture and data migration; the school district request covers speech, occupational, and other therapies for special education; the Santa Clara Health System posting seeks temporary staffing across ancillary clinical categories excluding nursing and physician roles. None of these opportunities directly relates to the detection, identification, or diagnostic analysis of contamination in transfused or infused blood products, plasma, tissues, or biologics—the core function the code nominally describes.

This code appears to carry a tagging mismatch with actual state and local procurement activity under it, suggesting either misclassification in the source system or minimal real-world procurement volume in this specific diagnostic service. Business development professionals evaluating this code should investigate whether issuing bodies and health systems are purchasing these diagnostic services under related codes (such as clinical laboratory testing or microbiology analysis codes) rather than this one, or whether the demand for contamination diagnosis of transfused and infused substances is too narrow to generate regular solicitation activity in the state and local market.